Changes After Suprachoroidal Injection.

• Status: Recruiting
• Trial end date: 2022-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Changes after suprachoroidal injection are analyzed for statistical analysis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Benha University
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Patients prepared to suprachoroidal injection for various retinal diseases will be enrolled in the study.

• Bilateral retinal diseases that required interventions as diabetic macular edema, exudative retinal detachment, and serous chorioretinopathies.

Exclusion Criteria:

• Other retinal diseases that are not expected to improve after steroid injections as central retinal artery occlusion and age-related macular degenerations.

• Choroidal neovascularization that require anti-vascular endothelial growth factors.

• Patients refused to have steroid injections even after discussing the nature of their disease with them and the procedure to be done.